PCSK9 inhibitors

PCSK9s appear to be meeting less payer resistance
Biopharma Dive
Thu, 04/12/18 - 11:00 pm
PCSK9 inhibitors
payers
The Moment Of Truth Is Coming For Struggling And Expensive Cholesterol Drugs
Forbes
Sun, 02/18/18 - 10:16 am
cholesterol
PCSK9 inhibitors
Sanofi
Regeneron
Praluent
Amgen
Repatha
NovoNordisk’s CSO openly addresses state of pharma sector
GoinPharma
Fri, 12/1/17 - 11:41 am
Novo Nordisk
Victoza
NASH
PCSK9 inhibitors
The Medicines Co., in pivot to pipeline PCSK9 med, secures $270M asset sale
Fierce Pharma
Wed, 11/29/17 - 10:15 am
The Medicines Company
PCSK9 inhibitors
inclisiran
Vabomere
The Medicines Company PCSK9 Inhibitor Strategy: More Heart Patients Via Lower Pricing
Forbes
Thu, 11/9/17 - 10:09 am
The Medicines Company
PCSK9 inhibitors
drug pricing
inclisiran
The Medicine Company's Dangerous Bet On Its LDL Cholesterol Lowering Drug
Forbes
Thu, 10/26/17 - 09:34 am
The Medicine Company
LDL cholesterol
inclisiran
Alnylam
PCSK9 inhibitors
PCSK9 court saga drags on for Sanofi, Regeneron and Amgen
Biopharma Dive
Mon, 10/9/17 - 09:36 am
Sanofi
Regeneron
Amgen
PCSK9 inhibitors
Praluent
Repatha
Sanofi and Amgen, eyeing boost for PCSK9 use, tout benefits for diabetes patients
Fierce Pharma
Mon, 09/18/17 - 11:08 am
Sanofi
Amgen
PCSK9 inhibitors
diabetes
Regeneron
Praluent
Repatha
Insurers, doctors battle over new heart disease drugs
CNBC
Fri, 09/8/17 - 09:30 am
insurers
cardiovascular disease
statins
PCSK9 inhibitors
Amgen
Regeneron
Sanofi
Repatha
Praluent
In cost debate, Amgen stands by Repatha's value
BioPharma Dive
Wed, 08/23/17 - 11:36 am
Amgen
Repatha
drug pricing
PCSK9 inhibitors
Praluent
Sanofi
Regeneron
ADA preview: 5 things to watch in diabetes
BioPharma Dive
Sun, 06/11/17 - 09:30 am
ADA
diabetes
Jardiance
Eli Lilly
Boehringer Ingelheim
Lantus
Tresiba
JNJ
Novo Nordisk
PCSK9 inhibitors
Amgen Regeneron
Sanofi
Apple
Google
insulin
Lilly, Pfizer, et al. back Sanofi and Regeneron in PCSK9 patent appeal. AbbVie doesn't
Fierce Pharma
Tue, 04/4/17 - 12:13 am
Eli Lilly
Pfizer
Sanofi
AbbVie
Regeneron
patents
PCSK9 inhibitors
Repatha
Amgen Identifies Issue with Patient Access to PCSK9 Inhibitor
Xtalks
Thu, 03/23/17 - 10:13 pm
Amgen
patients
PCSK9 inhibitors
Repatha
When it comes to PCSK9s, payers resisted — and sales flopped
Medical Marketing and Media
Wed, 01/11/17 - 09:54 am
PCSK9 inhibitors
payers
Amgen
Sanofi
Regeneron
Repatha
Praluent
Sanofi, Regeneron one step closer to owing PCSK9 royalties as judge upholds Amgen patent ruling
Fierce Pharma
Thu, 01/5/17 - 09:20 am
Sanofi
Regeneron
PCSK9 inhibitors
Amgen
Praluent
Repatha
No early success for Regeneron, Sanofi in PhIII outcomes study for PCSK9 drug Praluent
Endpoints
Thu, 11/17/16 - 09:54 am
Regeneron
Sanofi
Praluent
PCSK9 inhibitors
Data in hand, The Medicines Co. speeds PCSK9 plans
BioPharma Dive
Wed, 11/16/16 - 10:09 am
The Medicines Company
PCSK9 inhibitors
inclisiran
Death Of Pfizer Heart Drug Shows The Challenges Of CV R&D And Why Companies Are Bowing Out
Forbes
Thu, 11/3/16 - 09:28 am
Pfizer
bococizumab
R&D
PCSK9 inhibitors
Pfizer Discontinues Development of PCSK9 Inhibitor
Xtalks
Wed, 11/2/16 - 09:57 am
Pfizer
PCSK9 inhibitors
bococizumab
These pricey cholesterol drugs aren’t selling. And that has the biotech industry sweating
Stat
Fri, 10/28/16 - 10:07 am
PCSK9 inhibitors
Amgen
Regeneron
Sanofi
Repatha
Praluent
statins

Pages